Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis

Chest

Volumn 119, Issue 4, 2001, Pages 1123-1130

  Coates, Allan L ^a   Allen, Paul D ^b   MacNeish, Clair F ^b   Ho, Sharon L ^a   Lands, Larry C ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cystic fibrosis; Inhaled antibiotics; Nebulization

Indexed keywords

ARGON;

ADOLESCENT; ADULT; AEROSOL; ARTICLE; BODY WEIGHT; BREATHING; BREATHING PATTERN; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; GAS FLOW; HUMAN; INHALER; INSPIRATORY CAPACITY; LOWER RESPIRATORY TRACT; LUNG MINUTE VOLUME; MASS SPECTROMETRY; NEBULIZATION; PARTICLE SIZE; PEDIATRICS; PNEUMOTACHYGRAPHY; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; UPPER RESPIRATORY TRACT; VALIDATION PROCESS;

EID: 0034918373     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.4.1123     Document Type: Article

References (41)

1. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
2. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa
3. Inhaled ceftazadime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa
4. Nebulized colomycin for early Pseudomonas colonization in cystic fibrosis
5. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis
6. Quantitative deposition of aerosolized gentamycin in cystic fibrosis
7. Pulmonary deposition of aerosols in children with cystic fibrosis
8. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe asthma
9. Efficacy of albuteral administered by nebulizer versus spacer device in children with acute asthma
10. Long-term tobramycin aerosol therapy in cystic fibrosis
11. Response of the normal infants to inhaled histamine
12. Dilution of nebulised aerosols by air entrainment in children
13. The influence of age on aerosol deposition in children with cystic fibrosis
14. Aerosolized drug delivery in the 90s
15. Drug delivery by nebulization: "Reality testing"
16. A streamlined anesthetic system
17. An evaluation of rebreathing with the Bain circuit system during anesthesia with spontaneous respiration
18. The diagnosis of cystic fibrosis: A consensus statement
19. Standardization of spirometry: 1994 Update
20. Measurement of lung volumes by plethysmography
21. Changes in the normal maximal expiratory flow-volume curve with growth and aging
22. The choice of jet nebulizer, nebulizing flow, and the addition of albuterol affects the output of tobramycin aerosols
23. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution
24. Factors influencing the rate of drug output during the course of wet nebulization
25. Statistical methods for assessing agreement between two methods of clinical measurement
26. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers
27. Calculated deposition of inhaled particles in the airway generation of normal subjects
28. Therapeutic aerosols: 1. Physical and practical considerations
29. Evaluation of jet nebulisers for use with gentamycin solution
30. A theory of aerosol deposition in the human respiratory tract
31. Deposition of aerosols in pulmonary disease
32. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis
33. Factors influencing the deposition of inhaled particles
34. Measurement of total lung aerosol deposition as an index of lung abnormality
35. Influence of two-phase gas-liquid interaction on aerosol deposition in airways
36. Pulmonary deposition of nebulised amiloride in cystic fibrosis: Comparison of two nebulisers
37. Standardisation in drug nebulisers: BS7711; part 3
38. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers
39. Extreme variability in aerosol output of the DeVilbiss 646 nebulizer
40. The effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers
41. The use of osmometry as a means of determining changes in drug concentration during jet nebulization